London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Not sure.Still waiting for trial results.I thought they would have been done a while back.C4xd has no private punters interested out of all the aim pharma really, apart from on the day the latest small molecule was outlicenced and the sp popped on open for 5 minutes and was sold down in a big way.
Huge sell at the close.Been falling for some time now.Has news been leaked !!!
Drifting at the mo.What happened to the phase 1 readout?
small buys showing as sells - IT'S GOING UP
I think polar capital could be offloading again and that’s what’s causing the share price weakness. Could get an RNS soon as there appears to be some large sells lately. Fundamentally looks good just got to be patient and ride it out.Would like to add more at these price when funds allow.
Yup. We are back to that original £5m of straight up buys at 35p again. SP won't be propped up as much so it's going to get exciting. There's no way it says at 35p, it either falls through or bounces hard.
IMO
This share was always a long play, let the science do its work and with our well connected bod, we will be handsomely rewarded if our products prove themselves. Gla
Dropping heavily now which is disappointing........
Well it was fun while it lasted
We need something here!
Moving up a wee bit.
Meh it's just one to sit on for months and take a profit. Nothing will happen for a while.
Like a parked Tesla indeed.At least not like a hyperloop in reverse bitcoin i guess!
Some nice, chunky, more institutional action over the last few days but not moving much.
A very quiet middle as well
Yea he owns £23m worth of shares at todays value I doubt he will be able to reverse out of that at speed!
Big player adding is a positive in my book
Richard Griffiths adding again.Follow the money,R G is no fool.
Yep, comes across as a confident person and well connected....roll on C4...gla
tv the other night?On the vaccine rollout documentary, he sounds like a really nice bloke.I was impressed by Bingham’s tenacity and team building and organisation ability too.
Good man, the more the merrier, we need as many strong backs as we can get to hold up this sp and even push it higher..gla
I have to say I was a bit taken aback by Dixon's comments on leaving the vax task force role. Seemed overly optimistic.
Still maybe the government connection will see some of the UK biotech fund cash come this way
The sp needs you..
Leave it out....I'm not 1 of "2 of us "....lol...anyway, I mostly sit in the shadows..gla
You do make me chuckle the way you seem to be having a conversation with yourself..lol..ps. keep it up though, I've noticed the sp gets higher every time you post...lol
EARLY STAGE ASSET DEVELOPMENT (ESAD)
? INDV-2000 (Selective Orexin 1 [OX1] receptor antagonist):
- Phase 1 Single Ascending Dose (SAD) study has completed and shows encouraging safety and pharmacokinetics in
healthy volunteers. The final Clinical Study Report is expected by the end of Q4-2021.
- The Phase 1 Multiple Ascending Dose (MAD) study is currently planned with the first subject anticipated to be dosed
in Q3-2021.